Healthcare
Orthofix Medical Inc.(OFIX)
Live Price
Offline$9.19
-2.75% today
1Y Change
-13.06%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $480.00M
- Revenue Growth
- +2.9%
- EPS Growth
- +30.9%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Orthofix Medical Inc. (OFIX) is a Healthcare stock with a market cap of $480.00M and listed on NASDAQ. The stock last traded around $9.19 and down 13.1% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +2.9%, EPS growth of +30.9%, a dividend yield of 0.0%. What stands out right now is revenue +2.9%, EPS +30.9%, free cash flow +85.9% with operating margin -8.3% and ROIC -10.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Stock Foundry combines OFIX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.9% vs +7.6% peer median
Operating Margin
Below sector median
-8.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +2.9% and EPS at +30.9%, with operating margin around -8.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.2% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | -2.0% | -2.1% | -21.9% |
2026 Feb 24, 2026 | +70.8% | +2.3% | +2.2% | -8.1% |
2025 Nov 4, 2025 | +66.7% | +0.7% | +3.4% | +7.1% |
Benchmark Edge
OFIX vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OFIX
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OFIX Max Drawdown
-43.31%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OFIX and SPY.
Company Overview
Orthofix Medical Inc.
NASDAQ Global Select
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
- Leadership
- Massimo Calafiore
- IPO Date
- Apr 24, 1992
- Employees
- 1.6k
- Street Address
- 3451 Plano Parkway
- Mailing
- Lewisville, TX, 75056
- Region
- Lewisville, TX, US
- Reporting Currency
- USD
- Investor Line
- 214 937 2000
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 7.4
- Price/Sales
- 0.6
- Price/Book
- 1.1
Growth
- Revenue
- +2.9%
- EPS
- +30.9%
- Free Cash Flow
- +85.9%
Profitability
- Gross Margin
- 67.1%
- Operating Margin
- -8.3%
- Net Margin
- -11.2%
- ROE
- -20.4%
- ROIC
- -10.0%
Balance Sheet
- Debt/Equity
- 0.51
- Current Ratio
- 2.45
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.